Mark Tryniski Biography and Net Worth

Director of CONMED

MARK E. TRYNISKI has served as a Director of the Company since May 2007 and was the Lead Independent Director from May 2009 until he became Chairman of the Board in February 2014. He is the President and Chief Executive Officer of Community Bank System, Inc. (NYSE: CBU), where he served as Executive Vice President and Chief Operating Officer from February 2004 through August 2006. From June 2003 through February 2004, Mr. Tryniski was the Chief Financial Officer. Prior to joining Community Bank in June 2003, Mr. Tryniski was a partner with PricewaterhouseCoopers LLP. Mr. Tryniski also serves on the Board of Directors of the New York Bankers Association as well as the New York Business Development Corporation. Mr. Tryniski holds a B.S. degree from the State University of New York at Oswego. The Board of Directors has determined that Mr. Tryniski is independent, and that he is an audit committee financial expert, within the meaning of the rules of the Securities and Exchange Commission.

Mr. Tryniski’s qualifications for election to CONMED’s Board include his extensive experience as an active Chief Executive Officer of a public financial institution as well as his financial and accounting expertise acquired through his experience as an audit partner with PricewaterhouseCoopers LLP. His exposure to, and familiarity with, banking and financial matters offers a number of contacts and level of familiarity with financial matters that is unique on the Board. Further, his experience engaging with shareholders makes him well-suited to serve in the role of Chairman of the Board.

What is Mark E. Tryniski's net worth?: The estimated net worth of Mark E. Tryniski is at least $8.31 million as of February 7th, 2019. Mr. Tryniski owns 119,497 shares of CONMED stock worth more than $8,308,626 as of December 30th. This net worth estimate does not reflect any other assets that Mr. Tryniski may own. Learn More about Mark E. Tryniski's net worth.
How do I contact Mark E. Tryniski?: The corporate mailing address for Mr. Tryniski and other CONMED executives is 525 FRENCH ROAD, UTICA NY, 13502. CONMED can also be reached via phone at (727) 392-6464. Learn More on Mark E. Tryniski's contact information.
Has Mark E. Tryniski been buying or selling shares of CONMED?: Mark E. Tryniski has not been actively trading shares of CONMED in the last ninety days. Learn More on Mark E. Tryniski's trading history.
Who are CONMED's active insiders?: CONMED's insider roster includes Pat Beyer (Insider), Brian Concannon (Director), Todd Garner (CFO), Curt Hartman (Chairman of the Board, CEO & President), Daniel Jonas (Insider), John Kennedy (EVP), Stanley Peters, III (VP), Peter Shagory (EVP), and Mark Tryniski (Director). Learn More on CONMED's active insiders.
Are insiders buying or selling shares of CONMED?: In the last twelve months, CONMED insiders bought shares 3 times. They purchased a total of 6,442 shares worth more than $446,732.92. In the last twelve months, insiders at the sold shares 1 times. They sold a total of 4,000 shares worth more than $287,280.00. The most recent insider tranaction occured on June, 14th when insider Stanley W Peters III sold 4,000 shares worth more than $287,280.00. Insiders at CONMED own 6.8% of the company. Learn More about insider trades at CONMED.
Information on this page was last updated on 6/14/2024.

Mark E. Tryniski Insider Trading History at CONMED

Mark E. Tryniski Buying and Selling Activity at CONMED

CONMED Company Overview

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Today's Range

Now: $69.53

$67.60

$69.68

50 Day Range

MA: $71.09

$62.12

$77.77

2 Week Range

Now: $69.53

$61.05

$113.68

Volume

85,079 shs

Average Volume

477,166 shs

Market Capitalization

$2.15 billion

P/E Ratio

16.52

Dividend Yield

1.14%

Beta

1.46

First JFK… next Elon?

From Porter & Company | Ad

I share with you in this special investigative documentary.